Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention

详细信息    查看全文

• 作者：Marc Laine ; Richard Toesca ; Julie Berbis ; Corinne Frere ; Pierre Barnay ; Michel Pansieri ; Jean-Pascal Peyre ; Pierre Michelet ; Jacques Bessereau ; Elise Camilleri ; Olfa Helaf ; Marjorie Camaleonte ; Franck Paganelli ; Fran?oise Dignat-George ; Laurent Bonello
• 关键词：ACS ; acute coronary syndrome ; PCI ; percutaneous coronary intervention ; HTPR ; high on-treatment platelet reactivity ; LTPR ; low on-treatment platelet reactivity ; VASP ; Vasodilator-stimulated phosphoprotein ; LD ; loading dose ; PR ; platelet reactivity ; STEMI
• 刊名：Thrombosis Research
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：132
• 期：1
• 页码：e15-e18
• 全文大小：272 K

文摘

Background

The level of platelet reactivity (PR) inhibition obtained after P2Y12-ADP receptor antagonist loading dose (LD) is associated with the ischemic and bleeding risk following percutaneous coronary intervention (PCI) in acute coronary syndromes (ACS).

Objective

We aimed to evaluate the level of PR inhibition achieved by a 180 mg LD of ticagrelor and the rate of high on-treatment platelet reactivity (HTPR) in ACS patients undergoing PCI.

Methods

We performed a multicentre prospective observational study enrolling ACS patients undergoing PCI. Patients were included if they were admitted for ST-elevation myocardial infarction or non ST-elevation ACS. To assess PR, a VASP index was measured at least 6 and within 24 hours following a 180 mg LD of ticagrelor. HTPR was defined as a VASP index ¡Ý 50 % .

Results

One hundred and fifteen patients were included: 31.3 % of STEMI, 49.6 % of NSTEMI and 19.1 % of unstable angina. Following ticagrelor LD the mean VASP index was 17 ¡À 14 % . However the response to ticagrelor was not uniform with a small inter-individual variability: inter quartile range: 7.6-22.8 % and a rate of HTPR of 3.5 % . A high number of patients, 65.6 % , had a VASP index < 16 % . None of the baseline characteristics of the study population was associated with PR. In addition, PR was similar in STEMI, NSTEMI and unstable angina (p = 0.9).

Conclusion

In ACS patients the level of PR inhibition achieved by a 180 mg loading dose of ticagrelor is not uniform and the rate of HTPR is 3.5 % . A high proportion of patients exhibited a VASP index < 16 % .